Abstract:333 field was opened for further investigations and the term “altered microbiota signature in T2D” was established. In this issue of Polish Archives of Internal Medicine (Pol Arch Intern Med), Salamon et al6 report on a small study where they investigated fecal microbiome in patients with T1DM, T2DM, and healthy controls. Using 16S ribosomal RNA next generation sequencing, the authors observed that patients with T2DM differed with respect to their microbiome from both T1DM subjects and healthy controls. Patients with T2DM were char acterized by a higher ratio of Firmicutes to Bac teroidetes and demonstrated reduced fecal con centrations of certain Ruminococcaceae, Lachno spiraceae, Clostridiales, Bacteroides, Anaerostipes, and Roseburia, whereas the concentrations of Ruminococcus, Enterobacteriaceae and Proteobacte ria, all rather proinflammatory bacterial strains, were increased. Proteobacteria are considered pro inflammatory and might be able to drive immune responses characterized by increased interferon γ expression.7 Concentrations of Akkermansia muciniphila, a rather well characterized commensal with mainly antidiabetic and anti inflammatory properties,8 were increased in T2DM patients in the study by Salomon et al,6 and the authors pro posed that accompanying metformin treatment might have caused this effect.9 The findings by Salamon et al6 with A muciniphila are in contrast to several other studies which have demonstrated that obesity and related metabolic dysfunction are characterized by decreased fecal concentrations of this bacterium.10 Interestingly, the microbiota composition in T1DM subjects did not differ sig nificantly from that in healthy controls.6 Some at tention regarding the presented results, however, is needed as authors could not provide data on di etary details and stool consistency, both factors substantially affecting gut microbiota composi tion. Furthermore, the number of analyzed pa tients was rather low (T1DM, n = 22; T2DM, n = 23; controls, n = 23). Despite these shortcomings, The human intestinal tract contains an enor mous number of bacteria, archaea, and virus es. Recent estimates announced that a ratio of 1.3 bacterial cells might exist for every 1 hu man cell.1 Early studies believed that genes of this microbial world mainly encode functions affecting pathways favoring digestion of com plex carbohydrates or the control of immunity, whereas recent evidence supports that the mi crobiota has major functions in the regulation of metabolic pathways in health and disease.2 It has been shown in the past years that obese human subjects exhibit a gut microbiome sig nature.3 Two major studies from the following years showed that such a microbiome signature might also exist in humans with type 2 diabe tes mellitus (T2DM).4,5 In the first metagenome wide association study, researchers from Chi na demonstrated an intestinal dysbiosis char acterized by a decrease in butyrate producing Roseburia intestinalis and Faecalibacterium prausnitzii.4 When analyzing potentially associated functions from this altered microbiota, an en richment in the membrane transport of sugars, branchedchain amino acid transport and sul phate reduction, and decreased butyrate bio synthesis could be observed. Most importantly, enriched functions also included an increase in oxidative stress pathways, offering the hypoth esis that there might be a direct link between an altered microbiota and the well known pro inflammatory state in T2DM patients. A sec ond metagenome study in patients with T2DM from Europe exhibited an increase in the abun dance of certain Lactobacillus species including Lactobacillus gasseri, Streptococcus mutans, and certain Clostridium bacteria, such as Clostridium clostridioforme, and decreases in other Clostridium species. Roseburia intestinalis and Faecalibacterium prausnitzii, both prototypic butyrate producers, were highly discriminant for T2DM.5 Although there were significant differences be tween these 2 studies, a new exciting research EDITORIAL

Similar bacterial signatures in the gut microbiota of type 1 and type 2 diabetes patients and its association with G protein-coupled receptor 41 and 43 gene expression

Differences of gut microbiota between type 2 diabetes and non-diabetic population

Characterization of the Oral Microbiome of Medicated Type-2 Diabetes Patients

Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study

Role of gut microbiota in type 2 diabetes pathophysiology

Changes in the Microbiota and their Roles in Patients with Type 2 Diabetes Mellitus

Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis

Gut microbiota composition and type 2 diabetes: Are these subjects linked Together?

Multiple Bacteria Associated with the More Dysbiotic Genitourinary Microbiomes in Patients with Type 2 Diabetes Mellitus

A study on the association between gut microbiota, inflammation, and type 2 diabetes

Association of and Gut Microbiota in Type 2 Diabetic Mellitus Patients and non-Diabetic Individuals

Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential

Distinct signatures of gut microbiota and metabolites in different types of diabetes: a population-based cross-sectional study

The Association of Targeted Gut Microbiota with Body Composition in Type 2 Diabetes Mellitus

Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes

Enterotype Bacteroides Is Associated with a High Risk in Patients with Diabetes: A Pilot Study

High-Resolution Taxonomic Characterization Reveals Novel Human Microbial Strains with Potential as Risk Factors and Probiotics for Prediabetes and Type 2 Diabetes

Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review

Microbiota and diabetes: an evolving relationship

Analysis of gut microbiota in obese population with type 2 diabetes mellitus

Microbiota and diabetes: an increasingly relevant association.